FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118474890> ?p ?o ?g. }

• W3118474890 abstract "Abstract Background Cholangiocarcinoma represents the second most common primary liver malignancy. The incidence rate has constantly increased over the last decades. Cholangiocarcinoma silent nature limits early diagnosis and prevents efficient treatment. Methods Immunoblotting and immunohistochemistry were used to assess the expression profiling of USP9X and EGLN3 in cholangiocarcinoma patients. ShRNA was used to silence gene expression. Cell apoptosis, cell cycle, CCK8, clone formation, shRNA interference and xenograft mouse model were used to explore biological function of USP9X and EGLN3. The underlying molecular mechanism of USP9X in cholangiocarcinoma was determined by immunoblotting, co-immunoprecipitation and quantitative real time PCR (qPCR). Results Here we demonstrated that USP9X is downregulated in cholangiocarcinoma which contributes to tumorigenesis. The expression of USP9X in cholangiocarcinoma inhibited cell proliferation and colony formation in vitro as well as xenograft tumorigenicity in vivo. Clinical data demonstrated that expression levels of USP9X were positively correlated with favorable clinical outcomes. Mechanistic investigations further indicated that USP9X was involved in the deubiquitination of EGLN3, a member of 2-oxoglutarate and iron-dependent dioxygenases. USP9X elicited tumor suppressor role by preventing degradation of EGLN3. Importantly, knockdown of EGLN3 impaired USP9X-mediated suppression of proliferation. USP9X positively regulated the expression level of apoptosis pathway genes de through EGLN3 thus involved in apoptosis of cholangiocarcinoma. Conclusion These findings help to understand that USP9X alleviates the malignant potential of cholangiocarcinoma through upregulation of EGLN3. Consequently, we provide novel insight into that USP9X is a potential biomarker or serves as a therapeutic or diagnostic target for cholangiocarcinoma." @default.
• W3118474890 created "2021-01-18" @default.
• W3118474890 creator A5002800784 @default.
• W3118474890 creator A5005431252 @default.
• W3118474890 creator A5007550435 @default.
• W3118474890 creator A5033906003 @default.
• W3118474890 creator A5045161758 @default.
• W3118474890 creator A5045643676 @default.
• W3118474890 creator A5051691879 @default.
• W3118474890 creator A5052346371 @default.
• W3118474890 creator A5052796656 @default.
• W3118474890 creator A5062285036 @default.
• W3118474890 creator A5064302611 @default.
• W3118474890 creator A5065852561 @default.
• W3118474890 creator A5068596699 @default.
• W3118474890 creator A5068948672 @default.
• W3118474890 creator A5084073876 @default.
• W3118474890 date "2021-06-10" @default.
• W3118474890 modified "2023-10-17" @default.
• W3118474890 title "USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3" @default.
• W3118474890 cites W1493074066 @default.
• W3118474890 cites W1823067028 @default.
• W3118474890 cites W1848050571 @default.
• W3118474890 cites W1970368087 @default.
• W3118474890 cites W1973077902 @default.
• W3118474890 cites W1976752846 @default.
• W3118474890 cites W1986005575 @default.
• W3118474890 cites W1988404496 @default.
• W3118474890 cites W2018394697 @default.
• W3118474890 cites W2020511385 @default.
• W3118474890 cites W2028700227 @default.
• W3118474890 cites W2040850487 @default.
• W3118474890 cites W2055010502 @default.
• W3118474890 cites W2063293266 @default.
• W3118474890 cites W2070303143 @default.
• W3118474890 cites W2075394689 @default.
• W3118474890 cites W2079669427 @default.
• W3118474890 cites W2095249039 @default.
• W3118474890 cites W2098624479 @default.
• W3118474890 cites W2133810023 @default.
• W3118474890 cites W2145610465 @default.
• W3118474890 cites W2147225705 @default.
• W3118474890 cites W2149020418 @default.
• W3118474890 cites W2163953596 @default.
• W3118474890 cites W2322658752 @default.
• W3118474890 cites W2336712588 @default.
• W3118474890 cites W2395907205 @default.
• W3118474890 cites W2408829989 @default.
• W3118474890 cites W2515158720 @default.
• W3118474890 cites W2527281195 @default.
• W3118474890 cites W2529334190 @default.
• W3118474890 cites W2560087117 @default.
• W3118474890 cites W2579719458 @default.
• W3118474890 cites W2591150846 @default.
• W3118474890 cites W2611315414 @default.
• W3118474890 cites W2612887652 @default.
• W3118474890 cites W2616119389 @default.
• W3118474890 cites W2751131402 @default.
• W3118474890 cites W2754104139 @default.
• W3118474890 cites W2770731734 @default.
• W3118474890 cites W2774520422 @default.
• W3118474890 cites W2782965096 @default.
• W3118474890 cites W2783958861 @default.
• W3118474890 cites W2800714669 @default.
• W3118474890 cites W2805670216 @default.
• W3118474890 cites W2889660697 @default.
• W3118474890 cites W2915554264 @default.
• W3118474890 cites W2916487026 @default.
• W3118474890 cites W2920849174 @default.
• W3118474890 cites W2921528227 @default.
• W3118474890 cites W2942656542 @default.
• W3118474890 cites W2948012423 @default.
• W3118474890 cites W2949307886 @default.
• W3118474890 cites W2954150107 @default.
• W3118474890 cites W2962079812 @default.
• W3118474890 cites W2964873355 @default.
• W3118474890 cites W2972446135 @default.
• W3118474890 cites W2979953464 @default.
• W3118474890 cites W2984894721 @default.
• W3118474890 cites W3015201441 @default.
• W3118474890 cites W3083622579 @default.
• W3118474890 cites W836710179 @default.
• W3118474890 doi "https://doi.org/10.1186/s12929-021-00738-2" @default.
• W3118474890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8191029" @default.
• W3118474890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34112167" @default.
• W3118474890 hasPublicationYear "2021" @default.
• W3118474890 type Work @default.
• W3118474890 sameAs 3118474890 @default.
• W3118474890 citedByCount "7" @default.
• W3118474890 countsByYear W31184748902022 @default.
• W3118474890 countsByYear W31184748902023 @default.
• W3118474890 crossrefType "journal-article" @default.
• W3118474890 hasAuthorship W3118474890A5002800784 @default.
• W3118474890 hasAuthorship W3118474890A5005431252 @default.
• W3118474890 hasAuthorship W3118474890A5007550435 @default.
• W3118474890 hasAuthorship W3118474890A5033906003 @default.
• W3118474890 hasAuthorship W3118474890A5045161758 @default.
• W3118474890 hasAuthorship W3118474890A5045643676 @default.
• W3118474890 hasAuthorship W3118474890A5051691879 @default.
• W3118474890 hasAuthorship W3118474890A5052346371 @default.

• next